CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The LYMON project focuses on developing advanced chiral plasmonic nanoparticles for catalysis in the pharmaceutical industry, particularly for anticancer drug production. By integrating magnetism into these nanoparticles, the project aims to enhance their recyclability and reduce waste in chemical processes.
Catalysis holds immense significance in chemical manufacturing, being a key player in developing sustainable industrial processes with limited energy & resource consumption.
In pharmaceutical industry, catalysis is crucial for enabling mass production of affordable life-saving drugs.
However, developing efficient catalysts for this sector poses a formidable challenge due to the inherent asymmetry of many biological processes.
This is particularly critical in producing anticancer drugs because th…
UNIVERSITA DEGLI STUDI DI PADOVA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Badajoz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
